BeyondSpring Inc. Debt Securities, Trading, Unrealized Gain
BeyondSpring Inc. (BYSI) reported Debt Securities, Trading, Unrealized Gain of $105.00 thousand for the 3-month period ending 2021-09-30, per its 6-K filed 2021-12-30.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingUnrealizedGain · last filed 2021-12-30
- BeyondSpring Inc. debt securities, trading, unrealized gain for the quarter ending 2021-09-30 was $105.00K.
| Period end | Debt Securities, Trading, Unrealized Gain 3 month | Debt Securities, Trading, Unrealized Gain 9 month |
|---|---|---|
| 2021-09-30 | $105.00K 6-K · filed 2021-12-30 | $105.00K 6-K · filed 2021-12-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |